Page 64 - MI-2-1
P. 64

Microbes & Immunity                                       ABO blood type and cancer risk: A complex relationship



               Med J. 1985;290(6469):671-673.                  88.  Bahardoust M, Dehkharghani MZ, Ebrahimi P, et al. Effect
                                                                  of ABO blood group on postoperative overall survival and
               doi: 10.1136/bmj.290.6469.671
                                                                  recurrence-free survival rate in patients with hepatocellular
            78.  Stamatakos M, Kontzoglou K, Safioleas P, Safioleas C,   carcinoma after hepatectomy: A multi-center retrospective
               Manti   C, Safioleas M. Breast cancer incidence in Greek   cohort study. BMC Surg. 2023;23(1):324.
               women in relation to ABO blood groups and Rh factor. Int
               Semin Surg Oncol. 2009;6:14.                       doi: 10.1186/s12893-023-02236-8
                                                               89.  Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the
               doi: 10.1186/1477-7800-6-14
                                                                  global cancer incidence and mortality in 2018: GLOBOCAN
            79.  Tryggvadottir L, Tulinius H, Robertson JM. Familial and   sources and methods. Int J Cancer. 2019;144(8):1941-1953.
               sporadic breast cancer cases in Iceland: A  comparison
               related to ABO blood groups and risk of bilateral breast      doi: 10.1002/ijc.31937
               cancer. Int J Cancer. 1988;42(4):499-501.       90.  Wang GN, Zhou S, Chen C, et al. O Blood type is associated
                                                                  with unfavorable distant-metastasis-free survival in female
               doi: 10.1002/ijc.2910420405
                                                                  patients with nasopharyngeal carcinoma: A  retrospective
            80.  Anderson DE, Haas C. Blood type  A and familial breast   study of 2439  patients from epidemic area.  J  Cancer.
               cancer. Cancer. 1984;54(9):1845-1849.              2019;10(5):1297-1306.

               doi: 10.1002/1097-0142(19841101)54:9<1845:aid-cncr2820     doi: 10.7150/jca.28372
               540913>3.0.co;2-5
                                                               91.  Stakišaitis D, Juknevičienė M, Ulys A,  et  al. ABO blood
            81.  Cao X, Wen ZS, Sun YJ, Li Y, Zhang L, Han YJ. Prognostic   group polymorphism has an impact on prostate, kidney
               value of ABO blood group in patients with surgically   and bladder cancer in association with longevity. Oncol Lett.
               resected colon cancer. Br J Cancer. 2014;111(1):174-180.  2018;16(1):1321-1331.
               doi: 10.1038/bjc.2014.302                          doi: 10.3892/ol.2018.8749
            82.  Rashid G, Bhat GA, Rather TB,  et al. ABO and Rhesus   92.  Kvist E, Krogh J, Hjortberg P. Prognostic variables in patients
               blood group markers as predictors in colorectal cancer:   with prostate cancer: Influence of blood group ABO (H),
               A  prospective observational study.  Medicine (Baltimore).   the Rhesus system, age, differentiation, tumour stage and
               2023;102(47):e36256.                               metastases. Int Urol Nephrol. 1992;24(4):417-423.
               doi: 10.1097/MD.0000000000036256                   doi: 10.1007/BF02550636
            83.  Jodat H, Jodat J, Khodadadi A, Talaiezadeh A, Joudaki N,   93.  Markt SC, Shui IM, Unger RH,  et al. ABO blood group
               Asadirad A. A study of association of ABO and Rh blood   alleles and prostate cancer risk: Results from the breast
               group with colorectal cancer in Khuzestan province, Iran.   and prostate cancer cohort consortium (BPC3).  Prostate.
               Int J Hematol Oncol Stem Cell Res. 2023;17(4):275-280.  2015;75(15):1677-1681.
               doi: 10.18502/ijhoscr.v17i4.13919                  doi: 10.1002/pros.23035
            84.  Khalili H, Wolpin BM, Huang ES, et al. ABO blood group   94.  Wajsman Z, Saroff J, Murphy GP. Blood group distribution
               and risk of colorectal cancer. Cancer Epidemiol Biomarkers   in prostatic cancer patients. J Surg Oncol. 1977;9(3):289-291.
               Prev. 2011;20(5):1017-1020.
                                                                  doi: 10.1002/jso.2930090311
               doi: 10.1158/1055-9965.EPI-10-1250
                                                               95.  Chastonay P, Hurlimann J, Gardiol D. Biological tissue
            85.  Li B, Tan B, Chen C, Zhao L, Qin L. Association between the   markers in benign and malignant disease of the human
               ABO blood group and risk of common cancers. J Evid Based   prostate.  Virchows Arch A  Pathol Anat Histopathol.
               Med. 2014;7(2):79-83.                              1986;410(3):221-229.
               doi: 10.1111/jebm.12098                            doi: 10.1007/BF00710828
            86.  Zhang WN, Liang WJ, Zhang Y,  et al. Molecular   96.  Ghazizadeh M, Kagawa S, Takigawa H, Kurokawa K,
               characteristics of patients with colorectal signet-ring cell   Numoto S. Specific red cell adherence test in benign and
               carcinoma with different ABO blood groups.  Heliyon.   malignant lesions of the prostate. Br J Urol. 1983;55(4):405-
               2024;10(13):e34220.                                407.
               doi: 10.1016/j.heliyon.2024.e34220                 doi: 10.1111/j.1464-410x.1983.tb03332.x
            87.  Wei S, Yi T, OuYang Z, Wu J. Association between ABO   97.  Abel PD, Marsh C, Henderson D, Leathem A, Powell PH,
               blood type and type I endometrial cancer: A retrospective   Williams G. Detection of blood group antigens in frozen
               study. J Obstet Gynaecol. 2023;43(1):2153026.      sections of prostatic epithelium. Br J Urol. 1987;59(5):430-435.
               doi: 10.1080/01443615.2022.2153026                 doi: 10.1111/j.1464-410x.1987.tb04841.x


            Volume 2 Issue 1 (2025)                         56                               doi: 10.36922/mi.3267
   59   60   61   62   63   64   65   66   67   68   69